-
1
-
-
0042358985
-
Cell culture: biology's new dimension
-
Abbott A. Cell culture: biology's new dimension. Nature 2003, 424:870-872.
-
(2003)
Nature
, vol.424
, pp. 870-872
-
-
Abbott, A.1
-
2
-
-
84879267570
-
HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain
-
Ai M., Qiu S., Lu Y., Fan Z. HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain. Cell. Signal. 2013, 25:1754-1761.
-
(2013)
Cell. Signal.
, vol.25
, pp. 1754-1761
-
-
Ai, M.1
Qiu, S.2
Lu, Y.3
Fan, Z.4
-
3
-
-
77955981271
-
In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues
-
Aubele M., Spears M., Ludyga N., Braselmann H., Feuchtinger A., Taylor K.J., Lindner K., Auer G., Stering K., Hofler H., Schmitt M., Bartlett J.M. In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br. J. Cancer 2010, 103:663-667.
-
(2010)
Br. J. Cancer
, vol.103
, pp. 663-667
-
-
Aubele, M.1
Spears, M.2
Ludyga, N.3
Braselmann, H.4
Feuchtinger, A.5
Taylor, K.J.6
Lindner, K.7
Auer, G.8
Stering, K.9
Hofler, H.10
Schmitt, M.11
Bartlett, J.M.12
-
4
-
-
53049087852
-
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
-
Aubele M., Walch A.K., Ludyga N., Braselmann H., Atkinson M.J., Luber B., Auer G., Tapio S., Cooke T., Bartlett J.M. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 2008, 99:1089-1095.
-
(2008)
Br. J. Cancer
, vol.99
, pp. 1089-1095
-
-
Aubele, M.1
Walch, A.K.2
Ludyga, N.3
Braselmann, H.4
Atkinson, M.J.5
Luber, B.6
Auer, G.7
Tapio, S.8
Cooke, T.9
Bartlett, J.M.10
-
5
-
-
0030827253
-
BRK tyrosine kinase expression in a high proportion of human breast carcinomas
-
Barker K.T., Jackson L.E., Crompton M.R. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997, 15:799-805.
-
(1997)
Oncogene
, vol.15
, pp. 799-805
-
-
Barker, K.T.1
Jackson, L.E.2
Crompton, M.R.3
-
6
-
-
0020456385
-
How does the extracellular matrix direct gene expression?
-
Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression?. J.Theor. Biol. 1982, 99:31-68.
-
(1982)
J.Theor. Biol.
, vol.99
, pp. 31-68
-
-
Bissell, M.J.1
Hall, H.G.2
Parry, G.3
-
7
-
-
78049516402
-
Deregulation of the cell cycle by breast tumor kinase (Brk)
-
Chan E., Nimnual A.S. Deregulation of the cell cycle by breast tumor kinase (Brk). Int. J. Cancer 2010, 127:2723-2731.
-
(2010)
Int. J. Cancer
, vol.127
, pp. 2723-2731
-
-
Chan, E.1
Nimnual, A.S.2
-
8
-
-
10044284340
-
Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin
-
Chen H.Y., Shen C.H., Tsai Y.T., Lin F.C., Huang Y.P., Chen R.H. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol. 2004, 24:10558-10572.
-
(2004)
Mol. Cell. Biol.
, vol.24
, pp. 10558-10572
-
-
Chen, H.Y.1
Shen, C.H.2
Tsai, Y.T.3
Lin, F.C.4
Huang, Y.P.5
Chen, R.H.6
-
9
-
-
0037429779
-
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
-
Citri A., Skaria K.B., Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 2003, 284:54-65.
-
(2003)
Exp. Cell Res.
, vol.284
, pp. 54-65
-
-
Citri, A.1
Skaria, K.B.2
Yarden, Y.3
-
10
-
-
0038713797
-
Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells
-
Derry J.J., Prins G.S., Ray V., Tyner A.L. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 2003, 22:4212-4220.
-
(2003)
Oncogene
, vol.22
, pp. 4212-4220
-
-
Derry, J.J.1
Prins, G.S.2
Ray, V.3
Tyner, A.L.4
-
11
-
-
83455236148
-
Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues
-
Drewitz M., Helbling M., Fried N., Bieri M., Moritz W., Lichtenberg J., Kelm J.M. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol. J. 2011, 6:1488-1496.
-
(2011)
Biotechnol. J.
, vol.6
, pp. 1488-1496
-
-
Drewitz, M.1
Helbling, M.2
Fried, N.3
Bieri, M.4
Moritz, W.5
Lichtenberg, J.6
Kelm, J.M.7
-
12
-
-
84901853867
-
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance
-
Easwaran H., Tsai H.C., Baylin S.B. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 2014, 54:716-727.
-
(2014)
Mol. Cell
, vol.54
, pp. 716-727
-
-
Easwaran, H.1
Tsai, H.C.2
Baylin, S.B.3
-
13
-
-
35148859334
-
Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate
-
Eddy S.F., Kane S.E., Sonenshein G.E. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 2007, 67:9018-9023.
-
(2007)
Cancer Res.
, vol.67
, pp. 9018-9023
-
-
Eddy, S.F.1
Kane, S.E.2
Sonenshein, G.E.3
-
14
-
-
84887840885
-
MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
-
Falkenberg N., Anastasov N., Rappl K., Braselmann H., Auer G., Walch A., Huber M., Hofig I., Schmitt M., Hofler H., Atkinson M.J., Aubele M. MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion. Br. J. Cancer 2013, 109:2714-2723.
-
(2013)
Br. J. Cancer
, vol.109
, pp. 2714-2723
-
-
Falkenberg, N.1
Anastasov, N.2
Rappl, K.3
Braselmann, H.4
Auer, G.5
Walch, A.6
Huber, M.7
Hofig, I.8
Schmitt, M.9
Hofler, H.10
Atkinson, M.J.11
Aubele, M.12
-
15
-
-
84883189052
-
Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells
-
Fan G., Lin G., Lucito R., Tonks N.K. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells. J.Biol. Chem. 2013, 288:24923-24934.
-
(2013)
J.Biol. Chem.
, vol.288
, pp. 24923-24934
-
-
Fan, G.1
Lin, G.2
Lucito, R.3
Tonks, N.K.4
-
16
-
-
34548313955
-
Clonogenic assay of cells invitro
-
Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells invitro. Nat. Protoc. 2006, 1:2315-2319.
-
(2006)
Nat. Protoc.
, vol.1
, pp. 2315-2319
-
-
Franken, N.A.1
Rodermond, H.M.2
Stap, J.3
Haveman, J.4
van Bree, C.5
-
17
-
-
84886028975
-
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells
-
Hongisto V., Jernstrom S., Fey V., Mpindi J.P., Kleivi Sahlberg K., Kallioniemi O., Perala M. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PloS One 2013, 8:e77232.
-
(2013)
PloS One
, vol.8
, pp. e77232
-
-
Hongisto, V.1
Jernstrom, S.2
Fey, V.3
Mpindi, J.P.4
Kleivi Sahlberg, K.5
Kallioniemi, O.6
Perala, M.7
-
18
-
-
33745208666
-
Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth invitro and invivo
-
Hu X., Su F., Qin L., Jia W., Gong C., Yu F., Guo J., Song E. Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth invitro and invivo. Biochem. Biophys. Res. Commun. 2006, 346:778-785.
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.346
, pp. 778-785
-
-
Hu, X.1
Su, F.2
Qin, L.3
Jia, W.4
Gong, C.5
Yu, F.6
Guo, J.7
Song, E.8
-
19
-
-
77955386089
-
PTK6 regulates IGF-1-induced anchorage-independent survival
-
Irie H.Y., Shrestha Y., Selfors L.M., Frye F., Iida N., Wang Z., Zou L., Yao J., Lu Y., Epstein C.B., Natesan S., Richardson A.L., Polyak K., Mills G.B., Hahn W.C., Brugge J.S. PTK6 regulates IGF-1-induced anchorage-independent survival. PloS One 2010, 5:e11729.
-
(2010)
PloS One
, vol.5
, pp. e11729
-
-
Irie, H.Y.1
Shrestha, Y.2
Selfors, L.M.3
Frye, F.4
Iida, N.5
Wang, Z.6
Zou, L.7
Yao, J.8
Lu, Y.9
Epstein, C.B.10
Natesan, S.11
Richardson, A.L.12
Polyak, K.13
Mills, G.B.14
Hahn, W.C.15
Brugge, J.S.16
-
20
-
-
79952232216
-
Global cancer statistics
-
Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. Cancer J. Clinicians 2011, 61:69-90.
-
(2011)
Cancer J. Clinicians
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
21
-
-
0034676337
-
Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation
-
Kamalati T., Jolin H.E., Fry M.J., Crompton M.R. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 2000, 19:5471-5476.
-
(2000)
Oncogene
, vol.19
, pp. 5471-5476
-
-
Kamalati, T.1
Jolin, H.E.2
Fry, M.J.3
Crompton, M.R.4
-
22
-
-
0029828544
-
Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor
-
Kamalati T., Jolin H.E., Mitchell P.J., Barker K.T., Jackson L.E., Dean C.J., Page M.J., Gusterson B.A., Crompton M.R. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J.Biol. Chem. 1996, 271:30956-30963.
-
(1996)
J.Biol. Chem.
, vol.271
, pp. 30956-30963
-
-
Kamalati, T.1
Jolin, H.E.2
Mitchell, P.J.3
Barker, K.T.4
Jackson, L.E.5
Dean, C.J.6
Page, M.J.7
Gusterson, B.A.8
Crompton, M.R.9
-
23
-
-
41949125812
-
Lapatinib: a sword with two edges
-
Kopper L. Lapatinib: a sword with two edges. Pathol. Oncol. Res. 2008, 14:1-8.
-
(2008)
Pathol. Oncol. Res.
, vol.14
, pp. 1-8
-
-
Kopper, L.1
-
24
-
-
35348905119
-
RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth
-
Kunigal S., Lakka S.S., Gondi C.S., Estes N., Rao J.S. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int. J. Cancer 2007, 121:2307-2316.
-
(2007)
Int. J. Cancer
, vol.121
, pp. 2307-2316
-
-
Kunigal, S.1
Lakka, S.S.2
Gondi, C.S.3
Estes, N.4
Rao, J.S.5
-
25
-
-
57749089652
-
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival
-
Law J.H., Habibi G., Hu K., Masoudi H., Wang M.Y., Stratford A.L., Park E., Gee J.M., Finlay P., Jones H.E., Nicholson R.I., Carboni J., Gottardis M., Pollak M., Dunn S.E. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 2008, 68:10238-10246.
-
(2008)
Cancer Res.
, vol.68
, pp. 10238-10246
-
-
Law, J.H.1
Habibi, G.2
Hu, K.3
Masoudi, H.4
Wang, M.Y.5
Stratford, A.L.6
Park, E.7
Gee, J.M.8
Finlay, P.9
Jones, H.E.10
Nicholson, R.I.11
Carboni, J.12
Gottardis, M.13
Pollak, M.14
Dunn, S.E.15
-
26
-
-
77956594900
-
RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells
-
Li C., Cao S., Liu Z., Ye X., Chen L., Meng S. RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells. Int. J. Cancer 2010, 127:1507-1516.
-
(2010)
Int. J. Cancer
, vol.127
, pp. 1507-1516
-
-
Li, C.1
Cao, S.2
Liu, Z.3
Ye, X.4
Chen, L.5
Meng, S.6
-
27
-
-
34347218991
-
Invitro scratch assay: a convenient and inexpensive method for analysis of cell migration invitro
-
Liang C.C., Park A.Y., Guan J.L. Invitro scratch assay: a convenient and inexpensive method for analysis of cell migration invitro. Nat. Protoc. 2007, 2:329-333.
-
(2007)
Nat. Protoc.
, vol.2
, pp. 329-333
-
-
Liang, C.C.1
Park, A.Y.2
Guan, J.L.3
-
28
-
-
33746897689
-
Identification of STAT3 as a specific substrate of breast tumor kinase
-
Liu L., Gao Y., Qiu H., Miller W.T., Poli V., Reich N.C. Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene 2006, 25:4904-4912.
-
(2006)
Oncogene
, vol.25
, pp. 4904-4912
-
-
Liu, L.1
Gao, Y.2
Qiu, H.3
Miller, W.T.4
Poli, V.5
Reich, N.C.6
-
29
-
-
0032789582
-
BRK/Sik expression in the gastrointestinal tract and in colon tumors
-
Llor X., Serfas M.S., Bie W., Vasioukhin V., Polonskaia M., Derry J., Abbott C.M., Tyner A.L. BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin. Cancer Res. 1999, 5:1767-1777.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 1767-1777
-
-
Llor, X.1
Serfas, M.S.2
Bie, W.3
Vasioukhin, V.4
Polonskaia, M.5
Derry, J.6
Abbott, C.M.7
Tyner, A.L.8
-
30
-
-
79954459766
-
Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer
-
Ludyga N., Anastasov N., Gonzalez-Vasconcellos I., Ram M., Hofler H., Aubele M. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer. Mol. Biosystems 2011, 7:1603-1612.
-
(2011)
Mol. Biosystems
, vol.7
, pp. 1603-1612
-
-
Ludyga, N.1
Anastasov, N.2
Gonzalez-Vasconcellos, I.3
Ram, M.4
Hofler, H.5
Aubele, M.6
-
31
-
-
84876514602
-
Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells
-
Ludyga N., Anastasov N., Rosemann M., Seiler J., Lohmann N., Braselmann H., Mengele K., Schmitt M., Hofler H., Aubele M. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells. Mol. Cancer Res. 2013, 11:381-392.
-
(2013)
Mol. Cancer Res.
, vol.11
, pp. 381-392
-
-
Ludyga, N.1
Anastasov, N.2
Rosemann, M.3
Seiler, J.4
Lohmann, N.5
Braselmann, H.6
Mengele, K.7
Schmitt, M.8
Hofler, H.9
Aubele, M.10
-
32
-
-
0030763257
-
Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk
-
Mitchell P.J., Barker K.T., Shipley J., Crompton M.R. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk. Oncogene 1997, 15:1497-1502.
-
(1997)
Oncogene
, vol.15
, pp. 1497-1502
-
-
Mitchell, P.J.1
Barker, K.T.2
Shipley, J.3
Crompton, M.R.4
-
33
-
-
34547854801
-
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
-
Moasser M.M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007, 26:6469-6487.
-
(2007)
Oncogene
, vol.26
, pp. 6469-6487
-
-
Moasser, M.M.1
-
34
-
-
34248327833
-
Counting colonies of clonogenic assays by using densitometric software
-
Niyazi M., Niyazi I., Belka C. Counting colonies of clonogenic assays by using densitometric software. Radiat. Oncol. 2007, 2:4.
-
(2007)
Radiat. Oncol.
, vol.2
, pp. 4
-
-
Niyazi, M.1
Niyazi, I.2
Belka, C.3
-
35
-
-
34249339776
-
Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
-
Ostrander J.H., Daniel A.R., Lofgren K., Kleer C.G., Lange C.A. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 2007, 67:4199-4209.
-
(2007)
Cancer Res.
, vol.67
, pp. 4199-4209
-
-
Ostrander, J.H.1
Daniel, A.R.2
Lofgren, K.3
Kleer, C.G.4
Lange, C.A.5
-
36
-
-
84890150360
-
Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
-
Peng M., Ball-Kell S.M., Franks R.R., Xie H., Tyner A.L. Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models. Oncogene 2013, 2:e81.
-
(2013)
Oncogene
, vol.2
, pp. e81
-
-
Peng, M.1
Ball-Kell, S.M.2
Franks, R.R.3
Xie, H.4
Tyner, A.L.5
-
37
-
-
59649109230
-
Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab
-
Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009, 28:461-468.
-
(2009)
Oncogene
, vol.28
, pp. 461-468
-
-
Pickl, M.1
Ries, C.H.2
-
38
-
-
24644462342
-
Interaction between Brk kinase and insulin receptor substrate-4
-
Qiu H., Zappacosta F., Su W., Annan R.S., Miller W.T. Interaction between Brk kinase and insulin receptor substrate-4. Oncogene 2005, 24:5656-5664.
-
(2005)
Oncogene
, vol.24
, pp. 5656-5664
-
-
Qiu, H.1
Zappacosta, F.2
Su, W.3
Annan, R.S.4
Miller, W.T.5
-
39
-
-
4043140196
-
HER-2/neu testing in breast cancer
-
Ross J.S., Fletcher J.A., Bloom K.J., Linette G.P., Stec J., Clark E., Ayers M., Symmans W.F., Pusztai L., Hortobagyi G.N. HER-2/neu testing in breast cancer. Am. J. Clin. Pathol. 2003, (Suppl. 120):S53-S71.
-
(2003)
Am. J. Clin. Pathol.
, pp. S53-S71
-
-
Ross, J.S.1
Fletcher, J.A.2
Bloom, K.J.3
Linette, G.P.4
Stec, J.5
Clark, E.6
Ayers, M.7
Symmans, W.F.8
Pusztai, L.9
Hortobagyi, G.N.10
-
40
-
-
0038499519
-
Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases
-
Serfas M.S., Tyner A.L. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol. Res. 2003, 13:409-419.
-
(2003)
Oncol. Res.
, vol.13
, pp. 409-419
-
-
Serfas, M.S.1
Tyner, A.L.2
-
41
-
-
36249003805
-
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
-
Sergina N.V., Moasser M.M. The HER family and cancer: emerging molecular mechanisms and therapeutic targets. Trends Mol. Med. 2007, 13:527-534.
-
(2007)
Trends Mol. Med.
, vol.13
, pp. 527-534
-
-
Sergina, N.V.1
Moasser, M.M.2
-
42
-
-
0028358856
-
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
-
Sliwkowski M.X., Schaefer G., Akita R.W., Lofgren J.A., Fitzpatrick V.D., Nuijens A., Fendly B.M., Cerione R.A., Vandlen R.L., Carraway K.L. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J.Biol. Chem. 1994, 269:14661-14665.
-
(1994)
J.Biol. Chem.
, vol.269
, pp. 14661-14665
-
-
Sliwkowski, M.X.1
Schaefer, G.2
Akita, R.W.3
Lofgren, J.A.4
Fitzpatrick, V.D.5
Nuijens, A.6
Fendly, B.M.7
Cerione, R.A.8
Vandlen, R.L.9
Carraway, K.L.10
-
43
-
-
0035259989
-
Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials
-
Sparano J.A. Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials. Semin. Oncol. 2001, 28:20-27.
-
(2001)
Semin. Oncol.
, vol.28
, pp. 20-27
-
-
Sparano, J.A.1
-
44
-
-
84859109522
-
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer
-
Spears M., Taylor K.J., Munro A.F., Cunningham C.A., Mallon E.A., Twelves C.J., Cameron D.A., Thomas J., Bartlett J.M. In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer. Breast Cancer Res. Treat. 2012, 132:463-470.
-
(2012)
Breast Cancer Res. Treat.
, vol.132
, pp. 463-470
-
-
Spears, M.1
Taylor, K.J.2
Munro, A.F.3
Cunningham, C.A.4
Mallon, E.A.5
Twelves, C.J.6
Cameron, D.A.7
Thomas, J.8
Bartlett, J.M.9
-
45
-
-
33744725239
-
SiRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells
-
Subramanian R., Gondi C.S., Lakka S.S., Jutla A., Rao J.S. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int. J. Oncol. 2006, 28:831-839.
-
(2006)
Int. J. Oncol.
, vol.28
, pp. 831-839
-
-
Subramanian, R.1
Gondi, C.S.2
Lakka, S.S.3
Jutla, A.4
Rao, J.S.5
-
46
-
-
0014984766
-
Growth of multicell spheroids in tissue culture as a model of nodular carcinomas
-
Sutherland R.M., McCredie J.A., Inch W.R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J.Natl. Cancer Inst. 1971, 46:113-120.
-
(1971)
J.Natl. Cancer Inst.
, vol.46
, pp. 113-120
-
-
Sutherland, R.M.1
McCredie, J.A.2
Inch, W.R.3
-
47
-
-
0035073872
-
Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells
-
Wartenberg M., Donmez F., Ling F.C., Acker H., Hescheler J., Sauer H. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J. 2001, 15:995-1005.
-
(2001)
FASEB J.
, vol.15
, pp. 995-1005
-
-
Wartenberg, M.1
Donmez, F.2
Ling, F.C.3
Acker, H.4
Hescheler, J.5
Sauer, H.6
-
48
-
-
40349103609
-
Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6
-
Weaver A.M., Silva C.M. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Breast Cancer Res. 2007, 9:R79.
-
(2007)
Breast Cancer Res.
, vol.9
, pp. R79
-
-
Weaver, A.M.1
Silva, C.M.2
-
49
-
-
50549095021
-
Brk is coamplified with ErbB2 to promote proliferation in breast cancer
-
Xiang B., Chatti K., Qiu H., Lakshmi B., Krasnitz A., Hicks J., Yu M., Miller W.T., Muthuswamy S.K. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc. Natl. Acad. Sci. U S A 2008, 105:12463-12468.
-
(2008)
Proc. Natl. Acad. Sci. U S A
, vol.105
, pp. 12463-12468
-
-
Xiang, B.1
Chatti, K.2
Qiu, H.3
Lakshmi, B.4
Krasnitz, A.5
Hicks, J.6
Yu, M.7
Miller, W.T.8
Muthuswamy, S.K.9
-
50
-
-
80052584394
-
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors
-
Zeng H., Belanger D.B., Curran P.J., Shipps G.W., Miao H., Bracken J.B., Arshad Siddiqui M., Malkowski M., Wang Y. Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors. Bioorg. Med. Chem. Lett. 2011, 21:5870-5875.
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 5870-5875
-
-
Zeng, H.1
Belanger, D.B.2
Curran, P.J.3
Shipps, G.W.4
Miao, H.5
Bracken, J.B.6
Arshad Siddiqui, M.7
Malkowski, M.8
Wang, Y.9
-
51
-
-
12544260290
-
Regulated association of protein kinase B/Akt with breast tumor kinase
-
Zhang P., Ostrander J.H., Faivre E.J., Olsen A., Fitzsimmons D., Lange C.A. Regulated association of protein kinase B/Akt with breast tumor kinase. J.Biol. Chem. 2005, 280:1982-1991.
-
(2005)
J.Biol. Chem.
, vol.280
, pp. 1982-1991
-
-
Zhang, P.1
Ostrander, J.H.2
Faivre, E.J.3
Olsen, A.4
Fitzsimmons, D.5
Lange, C.A.6
|